EUVIMEDEUVIMED entdecken
Crossref

FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner

Zhe Yin, Xiong Guo, Xiaolong Liang, Ziwei Wang

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02369-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2024. Verfasst von Zhe Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a serious malignant tumour with a high mortality rate and a poor prognosis. Recently, emerging evidence has suggested that N6-methyladenosine (m6A) modification plays a crucial regulatory role in cancer progression. However, the exact role of m6A regulatory factors FTO in GC is unclear. First, the expression of m6A methylation-related regulatory factors in clinical samples and the clinical data of the corresponding patients were obtained from The Cancer Genome Atlas (TCGA-STAD) dataset, and correlation analysis between FTO expression and patient clinicopathological parameters was subsequently performed. qRT-PCR, immunohistochemistry (IHC) and western blotting (WB) were used to verify FTO expression in GC. CCK-8, EdU, flow cytometry and transwell assays were used to evaluate the effect of FTO on the behaviour of GC cells. Transcriptome sequencing and RNA immunoprecipitation analysis were used to explore the potential regulatory mechanisms mediated by FTO. FTO was highly expressed in GC tissues and cells, and high expression of FTO predicted a worse prognosis than low expression. Functionally, overexpression of FTO promoted the proliferation, migration and invasion of GC cells but inhibited cell apoptosis. Mechanistically, we found that FTO is upregulated in GC and promotes GC progression by modulating the expression of MAP4K4. Taken together, our findings provide new insights into the effects of FTO-mediated m6A demethylation and could lead to the development of new strategies for GC monitoring and aggressive treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenineHumansPrognosisGene Expression Regulation, NeoplasticDemethylationProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsAlpha-Ketoglutarate-Dependent Dioxygenase FTO

Stichwörter der Autor:innen

FTOGastric cancerMAP4K4m6A

Substanzen

6-methyladenineMAP4K4 protein, humanProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsFTO protein, humanAlpha-Ketoglutarate-Dependent Dioxygenase FTOAdenine

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China.
  • Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing, 400030, People's Republic of China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China. wangziwei@hospital.cqmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yin, Z., Guo, X., Liang, X., & Wang, Z. (2024). FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner. Medical Oncology. https://doi.org/10.1007/s12032-024-02369-7

Vancouver

Yin Z, Guo X, Liang X, Wang Z. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner. Medical Oncology. 2024. doi:10.1007/s12032-024-02369-7

BibTeX
@article{Yin2024,
  author = {Yin, Zhe and Guo, Xiong and Liang, Xiaolong and Wang, Ziwei},
  title = {FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02369-7}
}
Kostenlos starten →